FDA inspects Bridge Pacific 2, LLC in Montebello for biological hazards on March 3

Benjamin D. Moncarz Chief Financial Officer - FDA
Benjamin D. Moncarz Chief Financial Officer - FDA
0Comments

The Food and Drug Administration (FDA) carried out an inspection of Bridge Pacific 2, LLC in Montebello on March 3, focusing on foodborne biological hazards, according to information from the FDA’s website.

The inspection’s final outcome stated Bridge Pacific 2, LLC was not required to make any changes to its management operations.

The FDA regularly evaluates facilities nationwide to ensure workplaces and their products adhere to laws and regulations enforced for public health. Results from these inspections are published publicly.

According to the agency’s website, the FDA is the federal body tasked chiefly with overseeing the safety and quality of human and animal drugs, biological products, medical supplies and tobacco goods.

Information for this report was sourced from the U.S. Food and Drug Administration. Access the original source data here.



Related

Dr. Mehmet Oz CMS Administrator

Bellflower sees $1,317,283 in Medicaid spending on alcohol and drug abuse treatment in 2024

In 2024, Bellflower Medicaid providers billed $1,317,283 for Alcohol and Drug Abuse Treatment—a 149.5% rise over the prior year, according to federal data.

Dr. Mehmet Oz CMS Administrator

Maywood Medicaid bills for medicine services rise to $119,596 in 2024

Medicaid providers in Maywood billed $119,596 for Medicine Services and Procedures in 2024, marking an 8.7% increase from the prior year.

Dr. Mehmet Oz CMS Administrator

Compton Medicaid anesthesia payments reach $1.1 million, rising 10.7% in 2024

Medicaid claims for anesthesia-related care in Compton totaled $1,118,635 in 2024, representing a 10.7% uptick from the prior year.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from SE LA Times.